Results 221 to 230 of about 44,760 (265)

Druggable β-catenin palmitoyl-switch coordinates immune evasion via immunogenic ferroptosis resistance and PD-L1-mediated immunosuppression. [PDF]

open access: yesCell Rep Med
Zhang Q   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies

Pharmacology & Therapeutics, 2014
HMGB1 (High-Mobility Group Box-1) is a nuclear protein that acts as an architectural chromatin-binding factor involved in the maintenance of nucleosome structure and regulation of gene transcription. It can be released into the extracellular milieu from immune and non-immune cells in response to various stimuli.
Giovanni Nicola Roviello   +2 more
exaly   +5 more sources

The release and activity of HMGB1 in ferroptosis

Biochemical and Biophysical Research Communications, 2019
Damage-associated molecular pattern molecules (DAMPs) are endogenous danger signals that alert the innate immune system and shape the inflammation response to cell death. However, the release and activity of DAMPs in ferroptosis, a recently identified form of regulated necrosis characterized by iron overload and lipid peroxidation, still remain poorly ...
Daolin Tang, Rui Kang, Jiao Liu
exaly   +3 more sources

HMGB1 in Sepsis

Scandinavian Journal of Infectious Diseases, 2003
HMGB1 is a member of the high-mobility group protein superfamily that has been widely studied as nuclear proteins that bind DNA, stabilize nucleosomes and facilitate gene transcription. A series of recent discoveries revealed a cytokine activity of HMGB1, that when secreted into the extracellular milieu, mediates downstream inflammatory responses in ...
Ulf, Andersson, Kevin J, Tracey
openaire   +2 more sources

Home - About - Disclaimer - Privacy